USPTO serial 77467346
HISTASHIELD
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- THOMPSON, HEATHER
- Law office
- DIVISIONAL UNIT
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with HISTASHIELD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer L. Whitelaw
JENNIFER L. WHITELAW WHITELAW LEGAL GROUP3838 TAMIAMI TRL N FL 3NAPLES, FL 34103-3590UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | botanical extracts for use in the manufacture of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection; chemical extracts and active principles extracted from medicinal plants for use in the pharmaceutical industry, namely, chemical agents made from botanical extracts or associations of chemical extracts for use in the manufacture of pharmaceutical or nutraceutical products; botanicals and botanical blends, herbs and herbal blends, botanical extracts and botanical extract blends, flavor extracts and flavor extract blends, all for use in the manufacture of nutritional supplements and vitamins; herbal preparations and extracts for use as ingredients in manufacturing in the food, nutritional, nutraceutical and/or pharmaceutical industries | ACTIVE | — |
| 005 | herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; botanical extracts used as pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection; nutritional supplements; herbal products, namely, medicated skin and lip balms; herbal products, namely, ointments, oils, drinks, infusions, syrups, herbal extracts, and tinctures for medical use in the treatment of strokes, infarcts and other cardiovascular and cerebrum diseases; herbal products for medicinal purposes, namely, herbal extracts and syrups; herbal products, namely, herbal powders in nutritional supplement drink mixes for nutritional purposes; herbal products, namely, herbal powders for nutritional purposes; herbal products, namely, herbal meal replacement powders for dietary and nutritional purposes; nutritional dietary supplements; oral preparations containing herbs or herbal extracts used to maintain health and for a wide variety of physical conditions; vitamin and mineral preparations intended for use as dietary supplements; vitamins; pharmaceutical preparations, namely, appetite suppressants and lipid lowering agents; food for medically restricted diets; food for diabetics, infants and enteral feeding; medicinal herb extracts; medicinal herb extracts for medical purposes; plant extracts for medical or pharmaceutical purposes; yeast extracts for medical or pharmaceutical purposes; botanical extracts for nutritional use and botanical extracts for use as nutraceuticals and pharmaceuticals; botanical extracts used as nutritional supplements, nutraceuticals and pharmaceuticals; medicinal extracts used as pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection; anti-cough drops; cough drops; cough expectorants; cough lozenges; throat lozenges; cough syrups; cough treatment preparations; cold sore treatment preparations; pharmaceutical antitussive-cold preparations; preparations for treating colds; analgesic preparations; analgesics; antipyretic analgesics; ibuprofen for use as an oral analgesic; multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; oral analgesics; topical analgesics; homeopathic preparations for the treatment of herpes and cold sores; plant based antivirals; over-the-counter topical antivirals; pharmaceutical preparation with antiviral and/or antimicrobial properties for use in the treatment of herpetic keratitis, conjunctivitis, HIV retinopathy, viral influenza "flu", varicella zoster virus "herpes zoster" "shingles", cytomegalovirus, viral parainfluenza, adenovirus, viral encephalits, viral meningitis, arbovirus, arenavirus, picornavirus, coronavirus, syntialvirus, viral infections, common colds caused by viruses, cold sores, human immune deficiency virus "HIV" and roseola infantum; botanical extracts for use as nutritional supplements and nutraceuticals; plant extracts for medical and pharmaceutical purposes; botanicals and botanical blends, herbals and herbal blends, botanical extracts and botanical extract blends, flavor extracts and flavor extract blends, all sold as nutritional supplements and vitamins | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HerbalScience Group, LLC
- Other trademarks owned by HerbalScience Group, LLC
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named HISTASHIELD
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 9, 2010 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 9, 2010 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 24, 2010 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 24, 2010 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Feb 19, 2010 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 14, 2009 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 14, 2009 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Dec 14, 2009 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Dec 14, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 25, 2009 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 25, 2009 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 25, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 6, 2009 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 14, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 24, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 11, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 11, 2008 | ALIE | ASSIGNED TO LIE | — |
| Sep 3, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 3, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 3, 2008 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 3, 2008 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 3, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 20, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| May 10, 2008 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| May 9, 2008 | NWAP | NEW APPLICATION ENTERED | — |